0000000000085113

AUTHOR

Juan García-de-lomas

showing 5 related works from this author

Evaluation of the in-vitro cidal activity and toxicity of a novel peroxygen biocide: 2-butanone peroxide

2007

The monomer of 2-butanone peroxide is a novel peroxygen derivative with potential use as biocide in the hospital environment. The aim of this study was to test the biocidal activity of different concentrations of the compound against American Tissue Culture Collection strains from 11 different micro-organisms, including bacteria, mycobacteria, spores, fungi and virus, following the European Standard guidelines. Toxicity tests were also carried out following United States Environmental Protection Agency Standards. 2-Butanone peroxide exhibited biocidal activity at 0.12% against Legionella pneumophila, at 0.5% against Escherichia coli, Pseudomonas aeruginosa and Enterococcus hirae, and at 1% …

Microbiology (medical)BiocideMicrococcaceaeGuinea PigsGram-Positive Bacteriamedicine.disease_causePeroxideMicrobiologychemistry.chemical_compoundEnterococcus hiraeGram-Negative BacteriaToxicity TestsAnimalsMedicinebiologybusiness.industryPseudomonas aeruginosaBiological activityGeneral Medicinebiology.organism_classificationButanonesPeroxidesInfectious DiseaseschemistryStaphylococcus aureusToxicityRabbitsbusinessDisinfectantsJournal of Hospital Infection
researchProduct

Susceptibility of Pseudomonas aeruginosa isolates to ceftazidime is unrelated to the expression of the outer membrane protein OprC.

1997

Previously, it has been postulated that the porin OprC facilitates the diffusion of ceftazidime through the outer membrane of Pseudomonas aeruginosa. To further investigate this claim, the outer membrane protein (OMP) profiles of 22 ceftazidime-susceptible clinical isolates were analyzed. No correlation was found between MIC values and the level of expression of OprC. Further, OprC was either undetectable or expressed in reduced amounts in 12 isolates. In contrast, OprF and OprE were present in all isolates studied. This study suggests that OprC is dispensable for the permeation of ceftazidime through the outer membrane of P. aeruginosa.

CeftazidimePorinsmedicine.disease_causePorinaCeftazidimeMicrobiologyBacterial ProteinsDrug DiscoverymedicineHumansPharmacology (medical)Antibacterial agentPharmacologybiologyPseudomonas aeruginosaGeneral Medicinebiology.organism_classificationCephalosporinsImipenemInfectious DiseasesOncologyMembrane proteinSpainPorinPseudomonas aeruginosaThienamycinsBacterial outer membranePseudomonadaceaemedicine.drugBacterial Outer Membrane ProteinsChemotherapy
researchProduct

Type-Specific Antibodies to Pneumococcal Capsular Polysaccharide Acquired either Naturally or after Vaccination with Prevenar in Children with Underl…

2006

ABSTRACT The antibody response to capsular polysaccharides of pneumococcal serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F elicited either naturally or after vaccination with Prevenar was investigated in a cohort of children ( n = 163) with underlying chronic or recurrent lung diseases at risk of developing pneumococcal pneumonia and ultimately invasive disease. Serum concentrations of serotype-specific antibodies, as measured by enzyme-linked immunosorbent assay, in unvaccinated children ( n = 88) were higher in nasopharyngeal carriers ( n = 10) than in noncarriers ( n = 78) both at baseline and during follow-up. However, the antibody levels depended on the serotype and age of the children. Dur…

Microbiology (medical)SerotypeLung DiseasesMaleHeptavalent Pneumococcal Conjugate VaccineAdolescentClinical BiochemistryImmunologyEnzyme-Linked Immunosorbent AssayMeningococcal VaccinesMeningococcal vaccineStatistics NonparametricPneumococcal VaccinesAntibody SpecificitymedicineImmunology and AllergyHumansChildLungbiologybusiness.industryPolysaccharides BacterialVaccinationAntibody titerInfantmedicine.diseaseVaccine ResearchAntibodies BacterialVaccinationmedicine.anatomical_structureChild PreschoolCohortPneumococcal pneumoniaImmunologyChronic Diseasebiology.proteinFemaleAntibodybusinessFollow-Up Studies
researchProduct

Influence of Haemophilus influenzae β-lactamase production and/or ftsI gene mutations on in vitro activity of and susceptibility rates to aminopenici…

2007

Microbiology (medical)Haemophilus InfectionsPenicillin binding proteinsmedicine.drug_classCephalosporinMicrobial Sensitivity TestsGene mutationmedicine.disease_causebeta-LactamasesMicrobiologyHaemophilus influenzaeAmp resistanceAmpicillinmedicineHumansPenicillin-Binding ProteinsPharmacology (medical)Mutationbusiness.industryGeneral MedicineHaemophilus influenzaeIn vitroCephalosporinsPhenotypeInfectious DiseasesSpainMutationAmpicillinbusinessAmpicillin Resistancemedicine.drugInternational Journal of Antimicrobial Agents
researchProduct

Meropenem Permeation through the Outer Membrane of <i>Pseudomonas aeruginosa</i> Can Involve Pathways Other than the OprD Porin Channel

1996

The outer membrane protein (OMP) OprD is the major channel through which carbapenems permeate the outer membrane of Pseudomonas aeruginosa. In this study, we analyzed the OMP profiles of several P. aeruginosa clinical isolates showing diminished susceptibility to imipenem while remaining susceptible to meropenem. All these isolates lacked OprD or showed a reduced expression of this porin. Susceptibility to meropenem was thus independent of the level of OprD expression, indicating that the antimicrobial could be taken up via an alternative route. The level of expression of OprC (70 kD) was also unrelated to meropenem susceptibility. Nevertheless, OMPs OprF and OprE were expressed by all isol…

PharmacologyImipenembiologyPseudomonas aeruginosaGeneral Medicinebiochemical phenomena metabolism and nutritionbacterial infections and mycosesbiology.organism_classificationmedicine.disease_causeMeropenemPorinaMicrobiologyInfectious DiseasesOncologyDrug DiscoveryPorinpolycyclic compoundsmedicinebacteriaPharmacology (medical)Bacterial outer membranemedicine.drugPseudomonadaceaeAntibacterial agentChemotherapy
researchProduct